Osteoporosis and inflammation

Abstract

SUMMARYSeveral inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, celiac disease, cystic fibrosis and chronic obstructive pulmonary disease have been associated to bone resorption. The link between osteoclast, macrophage colony stimulating factor and pro-inflammatory cytokines, especially tumor necrosis factor-α and interleukin-1 explain the association between inflammation and osteoporosis. These diseases are related to osteoporosis and high fracture risk independent of other risk factors common to inflammatory diseases such as reduced physical activity, poor nutritional status, hypovitaminosis D, decrease in calcium intake and glucocorticoid treatment. Erythrocyte sedimentation rate and C-reactive protein should always be performed, but the indication about when to perform the densitometry test should be analyzed for each disease. Bisphosphonates are nowadays the best choice of therapy but new medications such as denosumab, IL-1 receptor antagonist, and TNF-α antibody have risen as new potential treatments for osteoporosis secondary to inflammation. Arq Bras Endocrinol Metab. 2010;54(2):123-32 Keywords Osteoporosis; inflammation; arthritis, rheumatoid; lupus erythematosus, systemic; interleukin-1; tumor necrosis factor-alpha SUMÁRIO Diversas doenças inflamatórias têm sido associadas à reabsorção óssea, como a artrite reumatoide, o lúpus eritematoso sistêmico, a doença inflamatória intestinal, a doença celíaca, a fibrose cística e a doença pulmonar obstrutiva crônica. A ligação entre osteoclastos, fator estimulador de colônia de macrófagos e citocinas pró-inflamatórias, principalmente o fator de necrose tumoral-α e interleucina-1, explica a associação entre a inflamação e a osteoporose. Essas doenças estão relacionadas com osteoporose e aumento do risco de fratura, independentemente de outros fatores de risco comuns às doenças inflamatórias, tais como redução da atividade física, estado nutricional, hipovitaminose D, diminuição da ingestão de cálcio e uso de glicocorticoides. A velocidade de hemossedimentação e proteína C-reativa devem ser sempre realizadas, mas a indicação do exame de densitometria óssea deve ser analisada em cada doen ça. Os bisfosfonatos são atualmente a melhor opção de terapia, mas novos medicamentos, tais como denosumabe, antagonista do receptor de IL-1 e anticorpos anti-TNF-α, surgem como novos potenciais tratamentos para a osteoporose secundária à inflamação. Arq Bras Endocrinol Metab. 2010;54(2):123-32 Descritores Osteoporose; inflamação; artrite reumatoide; lúpus eritematoso sistêmico; interleucina-1; fator de necrose tumoral-alfa

Alert for bone alterations and low serum concentrations of vitamin D in patients with intestinal inflammatory disease

“…Secondarily, it may be due to prolonged corticosteroid therapy, nutritional changes such as poor calcium intake, vitamin D deficiency, alcoholism, and smoking. [9][10][11][12] In our study, we observed that, in women with IBD, fracture cases were more frequent among smokers, a factor already pointed out in another study, 9 which associated smoking with reduction of BMD and with increased risk of fractures. Souza et al described that the number of patients with low BMD between the two groups of IBD is equivalent.…”

Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study

“…No physical activity was found in about 40% of the patients, independently of the rheumatic disease, and the prevalence of falls was high, in particular in RA and PMR (about 20%). Immobilization due to pain from inflamed joints and impairment of physical activity are known key factors related to low BMD and are common in patients suffering from rheumatic diseases (55). The risk of falls may be higher in RA patients because of lower limb joint disease and muscle weakness (due to GCs therapy and disuse) (56).…”

Assessment of Vitamin D status In Patients of Chronic Low Back Pain of Unknown Etiology

“…RANK-RANKL osteoprotegerin system, modulated by vitamin D, directly influences the release of pro inflammatory cytokines. It is now known that vitamin D deficiency makes muscles weaker and that vitamin D repletion boosts muscle strength [17].…”